← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Matrisome Bio, Inc.
Wilmington, DE
$1,588,234
Total funding
2
Grants
Funding mix
By agency
NIH$1,588,234 · 2
By mechanism
R44$1,233,778 · 1
N43$354,456 · 1
Investigators at Matrisome Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an extracellular matrix-targeted theranostic radiopharmaceutical for metastatic lung cancer$1,233,778
R44 · FY2025 · CA
NOVEL THERANOSTIC RADIOLIGANDS TARGETING DISEASE-SPECIFIC EXTRACELLULAR MATRIX COMPONENTS SPECIFIC TO TUMOR AND METASTATIC LESIONS IN PATIENTS SUFFERING FROM HEREDITARY BREAST AND OVARIAN CANCER (HBOC$354,456
N43 · FY2025 · CA